You are here

systemic mastocytosis

Blueprint's Ayvakit picks up long-awaited FDA approval in indolent systemic mastocytosis

Fierce Pharma

Mon, 05/22/23 - 10:07 pm

Blueprint Medicines

indolent systemic mastocytosis

systemic mastocytosis

Ahead of FDA decision, Blueprint puts out full data for expanded Ayvakit label

Endpoints

Mon, 02/27/23 - 10:03 am

Blueprint Medicines

systemic mastocytosis

Blueprint gears up for Ayvakit expansion, with blockbuster sales on the line

Fierce Pharma

Fri, 02/17/23 - 11:21 am

Blueprint Medicines

systemic mastocytosis

Blueprint drug succeeds in rare disease study important to its market prospects

BioPharma Dive

Wed, 08/17/22 - 10:55 am

Blueprint Medicines

systemic mastocytosis

clinical trials

Rare Blood Disease Drug Win Marks Fourth Approval for Blueprint Medicines

BioSpace

Thu, 06/17/21 - 10:55 am

Blueprint Medicines

systemic mastocytosis

Blueprint hits goal in midphase rare disease trial, teeing up pivotal study

Fierce Biotech

Mon, 03/16/20 - 11:52 pm

Blueprint Medicines

clinical trials

systemic mastocytosis